Principal advantages:
- In the years 2016–2020, the Consortium took part in 52 commercial clinical trials, e.g. in multiple sclerosis, stroke, epilepsy and myasthenia gravis.
- Establishing an Early Phase Centre will make it possible to support clinical trials of all phases (1 through 4) across a wide range of therapeutic indications.
Additional informations
ul. Ziołowa 45/47, 40-635 Katowice
32 47 96 112 lub 32 479 61 14
cwbk@sum.edu.pl
https://cwbk.sum.edu.pl